| REVIEW ARTICLE |
|
| Year : 2009 | Volume
: 6
| Issue : 1 | Page : 29-40 |
|
|
Management of Hepatitis B in the peri-transplant period
Sanjiv Saigal1, Amit Basnotra1, AS Soin2
1 Department of Gastroenterology and Hepatology, Sir Ganga Ram Hospital, New Delhi, India
2 Liver Transplantation, Sir Ganga Ram Hospital, New Delhi, India
Correspondence Address:
Sanjiv Saigal
Room No. 313, Department of Gastroenterology, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi-110 060
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0972-9747.76903
|
|
|
Hepatitis B virus (HBV) infection is an important indication for liver transplantation worldwide. The most important concern is the prevention of viral recurrence in the post transplant period. With the introduction of Hepatitis B immunoglobulin, there has been a significance reduction in the rate of HBV recurrence with improved patient & graft survival rates. The combination of oral nucleosides along with Hepatitis B immunoglobulin has further reduced the rate of HBV recurrence, and currently the outcome of liver transplantation for HBV infection is comparable to other indications for liver transplantation. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
